119 related articles for article (PubMed ID: 2328201)
1. Synergism between 5-fluorouracil and N-methylformamide in HT29 human colon cancer line.
Laudonio N; Zupi G; Erba E; Leonetti C; D'Incalci M
Br J Cancer; 1990 Mar; 61(3):377-81. PubMed ID: 2328201
[TBL] [Abstract][Full Text] [Related]
2. Different effects of sequential combinations of N-methylformamide with 5-fluorouracil on human colon carcinoma cells growing in nude mice.
Arancia G; Leonetti C; Malorni W; Greco C; Formisano G; Marangolo M; Zupi G
J Cancer Res Clin Oncol; 1991; 117(4):351-8. PubMed ID: 2066356
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the cytotoxic effect of 5-fluorouracil by N-methylformamide on a human colon carcinoma cell line.
Zupi G; Marangolo M; Arancia G; Greco C; Laudonio N; Iosi F; Formisano G; Malorni W
Cancer Res; 1988 Nov; 48(21):6193-200. PubMed ID: 3167866
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel and N-methylformamide: in vitro interactions in human colon cancer cell line.
Valenti AM; Niero A; Monti G; Marangolo F; Marangolo M
Anticancer Res; 1997; 17(4A):2491-7. PubMed ID: 9252669
[TBL] [Abstract][Full Text] [Related]
5. Pemetrexed disodium combined with oxaliplatin, SN38, or 5-fluorouracil, based on the quantitation of drug interactions in human HT29 colon cancer cells.
Raymond E; Louvet C; Tournigand C; Coudray AM; Faivre S; De Gramont A; Gespach C
Int J Oncol; 2002 Aug; 21(2):361-7. PubMed ID: 12118332
[TBL] [Abstract][Full Text] [Related]
6. Effect of 5-fluorouracil on methotrexate transport and cytotoxicity in HT29 colon adenocarcinoma cells.
Chen MF; Chen LT; Boyce HW
Cancer Lett; 1995 Jan; 88(2):133-40. PubMed ID: 7874685
[TBL] [Abstract][Full Text] [Related]
7. Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft model.
Britten CD; Hilsenbeck SG; Eckhardt SG; Marty J; Mangold G; MacDonald JR; Rowinsky EK; Von Hoff DD; Weitman S
Cancer Res; 1999 Mar; 59(5):1049-53. PubMed ID: 10070962
[TBL] [Abstract][Full Text] [Related]
8. Enhancement by N-methylformamide of the effect of ionizing radiation on a human colon tumor xenografted in nude mice.
Dexter DL; Lee ES; Bliven SF; Glicksman AS; Leith JT
Cancer Res; 1984 Nov; 44(11):4942-6. PubMed ID: 6488157
[TBL] [Abstract][Full Text] [Related]
9. Effect of interferon on 5-fluorouracil-induced perturbations in pools of deoxynucleotide triphosphates and DNA strand breaks.
Wadler S; Horowitz R; Mao X; Schwartz EL
Cancer Chemother Pharmacol; 1996; 38(6):529-35. PubMed ID: 8823494
[TBL] [Abstract][Full Text] [Related]
10. N-(phosphonacetyl)-L-aspartate synergistically enhances the cytotoxicity of 5-fluorouracil/interferon-alpha-2a against human colon cancer cell lines.
Wadler S; Mao X; Bajaj R; Hallam S; Schwartz EL
Mol Pharmacol; 1993 Nov; 44(5):1070-6. PubMed ID: 8246910
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of radiation-induced DNA double-strand breaks and micronuclei in human colon carcinoma cells by N-methylformamide.
Tofilon PJ; Vines CM; Bill CA
Radiat Res; 1989 Jul; 119(1):166-75. PubMed ID: 2756107
[TBL] [Abstract][Full Text] [Related]
12. Sequence-dependent activity of the irinotecan-5FU combination in human colon-cancer model HT-29 in vitro and in vivo.
Guichard S; Cussac D; Hennebelle I; Bugat R; Canal P
Int J Cancer; 1997 Nov; 73(5):729-34. PubMed ID: 9398054
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic impact of dipyridamole: chemopotentiation of the cytotoxic combination 5-fluorouracil/cisplatin in an animal model of human bladder cancer.
Keane TE; Rosner GL; Gingrich JR; Poulton SH; Walther PJ
J Urol; 1991 Nov; 146(5):1418-24. PubMed ID: 1942313
[TBL] [Abstract][Full Text] [Related]
14. In vivo potentiation of 5-fluorouracil by leucovorin in murine colon carcinoma.
Nadal JC; Van Groeningen CJ; Pinedo HM; Peters GJ
Biomed Pharmacother; 1988; 42(6):387-93. PubMed ID: 3064823
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of radiation-induced DNA-protein crosslinking by N-methylformamide.
Arundel CM; Tofilon PJ
Radiat Res; 1987 May; 110(2):294-304. PubMed ID: 3575657
[TBL] [Abstract][Full Text] [Related]
16. N-methylformamide as a potential therapeutic approach in colon cancer.
Del Bufalo D; Bucci B; D'Agnano I; Zupi G
Dis Colon Rectum; 1994 Feb; 37(2 Suppl):S133-7. PubMed ID: 8313785
[TBL] [Abstract][Full Text] [Related]
17. Supra-additive antitumor activity of 5FU with tumor necrosis factor-related apoptosis-inducing ligand on gastric and colon cancers in vitro.
Shimoyama S; Mochizuki Y; Kusada O; Kaminishi M
Int J Oncol; 2002 Sep; 21(3):643-8. PubMed ID: 12168112
[TBL] [Abstract][Full Text] [Related]
18. Combination studies of antifolates with 5-fluorouracil in colon cancer cell lines.
van der Wilt CL; Kuiper CM; Peters GJ
Oncol Res; 1999; 11(8):383-91. PubMed ID: 10803742
[TBL] [Abstract][Full Text] [Related]
19. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of the responses of human colon adenocarcinoma cells to X-irradiation and cis-platinum by N-methylformamide (NMF).
Leith JT; Lee ES; Vayer AJ; Dexter DL; Glicksman AS
Int J Radiat Oncol Biol Phys; 1985 Nov; 11(11):1971-6. PubMed ID: 4055454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
